A new study by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP), the National Cancer Institute, and the Chulabhorn Research Institute has found that blocking the activity of a key immune receptor, the ...
Jul 24, 2015
0
37
What if eating an egg for breakfast is just as good as a bowl of oatmeal for people with diabetes? Maybe even better? Maria-Luz Fernandez, a professor of nutritional sciences in the College of Agriculture, Health, and Natural ...
May 27, 2015
0
52
The Feinstein Institute for Medical Research, the research arm of the North Shore-LIJ Health System, and SetPoint Medical Inc., a biomedical technology company, today released the results of research on the therapeutic potential ...
May 13, 2015
0
17
(HealthDay)—Genetic variations may hold clues to rheumatoid arthritis—suggesting not only who will develop the painful condition, but also predicting its severity and even who might die from it, a new study says.
Apr 28, 2015
0
117
Cells lining the intestinal tract form a critical barrier, protecting our bodies from the billions of bacteria living in the gut. Breaches in this barrier are driven largely by a single signaling molecule called tumor necrosis ...
Feb 16, 2015
0
589
In recent years, a standard follow-up to colorectal cancer surgery has been to analyze the tumor tissue for the presence of immune cells. Finding high quantities of cytotoxic T cells, or "killer cells", means that there is ...
Feb 2, 2015
0
9
Drugs that are on the market to treat erectile dysfunction (ED) could have another use—they might be able to protect the liver from damage caused by sepsis, a systemic inflammatory response to infection, say researchers ...
Jan 29, 2015
0
25
(HealthDay)—Combined inhibition of tumor necrosis factor (TNF) α and interleukin (IL)-17 is more effective than single blockade in cultures of human fibroblast-like synoviocytes (FLS), according to an experimental study ...
Jan 7, 2015
0
5
One of the family of drugs prescribed for rheumatoid arthritis and other inflammatory conditions is called TNF inhibitors. They act by dampening part of the immune system called tumor necrosis factor (TNF). In one of the ...
Nov 17, 2014
0
0
A molecule that helps cancer cells evade programmed self-destruction, an internal source of death, might also help malignant cells hide from the immune system, an external source of death.
Oct 7, 2014
0
0
